12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Debiopharm, Agency for Science, Technology and Research (A*STAR) deal

Debiopharm partnered with the Experimental Therapeutics Centre (ETC) research unit of A*STAR to exclusively develop oral small molecules targeting an...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >